Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinfeng Xu

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
American Journal of Infection Control|April 21, 2019
Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysisXingran Du, Xinfeng Xu, Jing Yao, et al.
Cancer Science|November 2, 2021
CPI-203 improves the efficacy of anti-PD-1 therapy by inhibiting the induced PD-L1 overexpression in liver cancerXiaoge Niu, Wei Wang, Taizhen Liang, et al.
International Journal of Molecular Sciences|April 13, 2024
<i>BcABF1</i> Plays a Role in the Feedback Regulation of Abscisic Acid Signaling via the Direct Activation of <i>BcPYL4</i> Expression in PakchoiXiaoxue Yang, Meiyun Wang, Qian Zhou, et al.
Frontiers in Immunology|October 13, 2025
The study of the relationship between food additives and the childhood asthma based on metabolome analysisMingcong Chen, Xinfeng Xu, Xinyao Jiang, et al.
European Journal of Pharmacology|December 6, 2020
T-type calcium channels blockers inhibit HSV-2 infection at the late stage of genome replicationLiqiong Ding, Ping Jiang, Xinfeng Xu, et al.
Viruses|August 29, 2024
CFTR Inhibitors Display Antiviral Activity against Herpes Simplex VirusPing Jiang, Zhong Dai, Chan Yang, et al.
Discover Oncology|February 4, 2024
CT imaging features of lung ground-glass nodule patients with upgraded intraoperative frozen pathologyHongya Wang, Aiping Chen, Kun Wang, et al.
Journal of Virology|June 16, 2021
TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4<sup>+</sup> T CellsSiqin Duan, Xinfeng Xu, Jinshen Wang, et al.
Biochemical Pharmacology|April 17, 2019
A novel bromodomain inhibitor, CPI-203, serves as an HIV-1 latency-reversing agent by activating positive transcription elongation factor bTaizhen Liang, Xuanxuan Zhang, Fangyuan Lai, et al.
Annals of Translational Medicine|March 14, 2022
Clinical significance of the diverse interlobar veins hidden in the upper oblique fissureXinfeng Xu, Jun Wang, Qiang Liu, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
American Journal of Infection Control|April 21, 2019
Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysisXingran Du, Xinfeng Xu, Jing Yao, et al.
Cancer Science|November 2, 2021
CPI-203 improves the efficacy of anti-PD-1 therapy by inhibiting the induced PD-L1 overexpression in liver cancerXiaoge Niu, Wei Wang, Taizhen Liang, et al.
International Journal of Molecular Sciences|April 13, 2024
<i>BcABF1</i> Plays a Role in the Feedback Regulation of Abscisic Acid Signaling via the Direct Activation of <i>BcPYL4</i> Expression in PakchoiXiaoxue Yang, Meiyun Wang, Qian Zhou, et al.
Frontiers in Immunology|October 13, 2025
The study of the relationship between food additives and the childhood asthma based on metabolome analysisMingcong Chen, Xinfeng Xu, Xinyao Jiang, et al.
European Journal of Pharmacology|December 6, 2020
T-type calcium channels blockers inhibit HSV-2 infection at the late stage of genome replicationLiqiong Ding, Ping Jiang, Xinfeng Xu, et al.
Viruses|August 29, 2024
CFTR Inhibitors Display Antiviral Activity against Herpes Simplex VirusPing Jiang, Zhong Dai, Chan Yang, et al.
Discover Oncology|February 4, 2024
CT imaging features of lung ground-glass nodule patients with upgraded intraoperative frozen pathologyHongya Wang, Aiping Chen, Kun Wang, et al.
Journal of Virology|June 16, 2021
TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4<sup>+</sup> T CellsSiqin Duan, Xinfeng Xu, Jinshen Wang, et al.
Biochemical Pharmacology|April 17, 2019
A novel bromodomain inhibitor, CPI-203, serves as an HIV-1 latency-reversing agent by activating positive transcription elongation factor bTaizhen Liang, Xuanxuan Zhang, Fangyuan Lai, et al.
Annals of Translational Medicine|March 14, 2022
Clinical significance of the diverse interlobar veins hidden in the upper oblique fissureXinfeng Xu, Jun Wang, Qiang Liu, et al.
Pageof 5